0

Latanoprost acid

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP41639832-B
CAS41639-83-2
Structure
MDL NumberMFCD08056084
Molecular Weight390.51
InChI KeyHNPFPERDNWXAGS-NFVOFSAMSA-N
Description≥98% (HPLC)
SolubilityDMSO: freely soluble; methanol: soluble
Assay≥98% (HPLC)
Colorpale yellow, oil
Size1MG, 5MG
Storage Conditions−20°C
1

Comparison of Human Ocular Distribution of Bimatoprost and Latanoprost

Parul Ichhpujani, L Jay Katz, Gabor Hollo, Carol L Shields, Jerry A Shields, Brian Marr, Ralph Eagle, Heryberto Alvim, Sheryl S Wizov, Andrew Acheampong, June Chen, Larry A Wheeler

J Ocul Pharmacol Ther. 2012 Apr;28(2):134-45.

PMID: 22136089

1

Effect of Latanoprost Acid and Pilocarpine on Cultured Rabbit Ciliary Muscle Cells

Yisheng Zhong, Jian Gao, Wen Ye, Ping Huang, Yu Cheng, Qin Jiao

Ophthalmic Res. 2007;39(4):232-40.

PMID: 17622744

1

Latanoprostene Bunod Ophthalmic Solution 0.024%: A New Treatment Option for Open-Angle Glaucoma and Ocular Hypertension

Murray Fingeret, Ian B Gaddie, Marc Bloomenstein

Clin Exp Optom. 2019 Nov;102(6):541-550.

PMID: 30614563

1

Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension

Sheridan M Hoy

Drugs. 2018 May;78(7):773-780.

PMID: 29761382

1

The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies

Megan E Cavet, Heleen H DeCory

J Ocul Pharmacol Ther. Jan/Feb 2018;34(1-2):52-60.

PMID: 28783422

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode